Hjem › Steatotisk leversykdom › Ohio
Kliniske studier for Steatotisk leversykdom i Ohio
15 studier for Steatotisk leversykdom søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07704892Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Cleveland Clinic, Cleveland
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05832229A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Akron Gastro Research, Akron
- Dayton Gastroenterology - Beavercreek, Beavercreek
- Clinical Research Institute of Ohio - Brooklyn, Brooklyn
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07165028Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 2
Alder 5 til 16 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06133101A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Akron
- Akero Clinical Study Site, Springboro
- Akero Clinical Study Site, Westlake
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Akron Gastro Research, Akron
- Digestive Specialists, Dayton
- DSI Research, Springboro
- og 1 flere
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
- og 4 flere
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Akron
- 89bio Clinical Study Site, Cincinnati
- 89bio Clinical Study Site, Cleveland
- og 5 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Cleveland
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Cleveland Clinic, Cleveland
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
Alder 18 til 75 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Akron
- GSK Investigational Site, Springboro
- GSK Investigational Site, Westlake
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07221227Milk Thistle Clinical Trial in Pediatric NAFLD
- University Hospitals Cleveland Medical Center, Cleveland
RekruttererFase 2
Alder 9 til 22 · Alle kjønn · Oppdatert 27. jan. 2026 · NCT06477146Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
- southwoods imaging (Northeastern Ohio Radiology Research and Education Fund ), Boardman
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2025 · NCT07192159Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Ohio Clinical Trials, Columbus
RekruttererObservasjonsstudie
Alder 18 til 75 · Alle kjønn · Oppdatert 14. aug. 2025 · NCT07122700Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.